ERBB2 and breast cancer: BC has been classified based on variations in gene expression into four groups: basal-like group, ERBB2-overexpressing group, estrogen receptor (ER) group, and normal-like group, and these groups are highly related to prognosis and clinical outcome prediction [2,3].